NEW DELHI (Reuters) – India will stick to its schedule of giving two doses of AstraZeneca (NASDAQ:)’s vaccine, a senior government adviser said on Tuesday.
“India’s Covishield schedule is of two doses… there is no change and Covaxin is also for two doses,” government advisor V K Paul told reporters at a news conference.
Mixing of vaccines is not a protocol and research is currently being conducted on this, he added.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.